Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
- PMID:22188182
- PMCID: PMC3288311
- DOI: 10.1111/j.1469-1809.2011.00694.x
Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
Abstract
Fragile X syndrome (FXS) is characterized by moderate to severe intellectual disability, which is accompanied by macroorchidism and distinct facial morphology. FXS is caused by the expansion of the CGG trinucleotide repeat in the 5' untranslated region of the fragile X mental retardation 1 (FMR1) gene. The syndrome has been studied in ethnically diverse populations around the world and has been extensively characterized in several populations. Similar to other trinucleotide expansion disorders, the gene-specific instability of FMR1 is not accompanied by genomic instability. Currently we do not have a comprehensive understanding of the molecular underpinnings of gene-specific instability associated with tandem repeats. Molecular evidence from in vitro experiments and animal models supports several pathways for gene-specific trinucleotide repeat expansion. However, whether the mechanisms reported from other systems contribute to trinucleotide repeat expansion in humans is not clear. To understand how repeat instability in humans could occur, the CGG repeat expansion is explored through molecular analysis and population studies which characterized CGG repeat alleles of FMR1. Finally, the review discusses the relevance of these studies in understanding the mechanism of trinucleotide repeat expansion in FXS.
Annals of Human Genetics © 2011 Blackwell Publishing Ltd/University College London Published 2011. This article is a US Government work and is in the public domain in the USA.
Similar articles
- CGG-repeat dynamics andFMR1 gene silencing in fragile X syndrome stem cells and stem cell-derived neurons.Zhou Y, Kumari D, Sciascia N, Usdin K.Zhou Y, et al.Mol Autism. 2016 Oct 6;7:42. doi: 10.1186/s13229-016-0105-9. eCollection 2016.Mol Autism. 2016.PMID:27713816Free PMC article.
- Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ.Sheridan SD, et al.PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12.PLoS One. 2011.PMID:22022567Free PMC article.
- FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.Sølvsten C, Nielsen AL.Sølvsten C, et al.Gene. 2011 Oct 15;486(1-2):15-22. doi: 10.1016/j.gene.2011.06.034. Epub 2011 Jul 13.Gene. 2011.PMID:21767618
- Mechanisms of Genome Instability in the Fragile X-Related Disorders.Hayward BE, Usdin K.Hayward BE, et al.Genes (Basel). 2021 Oct 17;12(10):1633. doi: 10.3390/genes12101633.Genes (Basel). 2021.PMID:34681027Free PMC article.Review.
- Unstable mutations in the FMR1 gene and the phenotypes.Loesch D, Hagerman R.Loesch D, et al.Adv Exp Med Biol. 2012;769:78-114. doi: 10.1007/978-1-4614-5434-2_6.Adv Exp Med Biol. 2012.PMID:23560306Free PMC article.Review.
Cited by
- PAK in Alzheimer disease, Huntington disease and X-linked mental retardation.Ma QL, Yang F, Frautschy SA, Cole GM.Ma QL, et al.Cell Logist. 2012 Apr 1;2(2):117-125. doi: 10.4161/cl.21602.Cell Logist. 2012.PMID:23162743Free PMC article.
- Experiences of the Molecular Diagnosis of Fragile X Syndrome in Ecuador.Pozo-Palacios J, Llamos-Paneque A, Rivas C, Onofre E, López-Cáceres A, Villareal J.Pozo-Palacios J, et al.Front Psychiatry. 2021 Dec 13;12:716311. doi: 10.3389/fpsyt.2021.716311. eCollection 2021.Front Psychiatry. 2021.PMID:34966298Free PMC article.
- CGG repeats in the human FMR1 gene regulate mRNA localization and cellular stress in developing neurons.Sirois CL, Guo Y, Li M, Wolkoff NE, Korabelnikov T, Sandoval S, Lee J, Shen M, Contractor A, Sousa AMM, Bhattacharyya A, Zhao X.Sirois CL, et al.Cell Rep. 2024 Jun 25;43(6):114330. doi: 10.1016/j.celrep.2024.114330. Epub 2024 Jun 11.Cell Rep. 2024.PMID:38865241Free PMC article.
- Prevalence and implications of fragile X premutation screening in Thailand.Hnoonual A, Kaewfai S, Limwongse C, Limprasert P.Hnoonual A, et al.Sci Rep. 2024 Nov 1;14(1):26257. doi: 10.1038/s41598-024-77762-3.Sci Rep. 2024.PMID:39482338Free PMC article.
- The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.Juvale IIA, Che Has AT.Juvale IIA, et al.J Mol Neurosci. 2021 Jul;71(7):1338-1355. doi: 10.1007/s12031-021-01825-7. Epub 2021 Mar 27.J Mol Neurosci. 2021.PMID:33774758Review.
References
- AL HUSAIN M, SALIH M, ZAKI O, AL OTHMAN L, AL NASSER M. Clinical study of mentally retarded children with fragile X syndrome in Saudi Arabia. Ann Saudi Med. 2000:16–19. - PubMed
- ANGELI C, CAPELLI L. AGG Interspersion pattern in the CGG repeat of the FMR1 gene and linked DXS548/FRAXAC1 haplotypes in Brazilian populations. Am J Med Genet A. 2005;132A:210–214. - PubMed
- ANTAR LN, BASSELL GJ. Sunrise at the Synapse: The FMRP mRNP Shaping the Synaptic Interface. Neuron. 2003;37:555–558. - PubMed
- ANTAR LN, DICTENBERG JB, PLOCINIAK M, AFROZ R, BASSELL GJ. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes, Brain and Behavior. 2005;4:350–359. - PubMed
- ARINAMI T, KONDO I, NAKAJIMA S. Frequency of the Fragile X syndrome in Japanese mentally retarded males. Hum Genet. 1986;73:309–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical